Figure 3. Effect of HLJG0701 on scopolamine-induced memory deficit in the Y-maze test. Mice in different groups were administered with saline (control, CON), scopolamine (1 mg/kg, i.p., SPL-G), HLJG0701 (150 mg/kg, HG-150; 300 mg/kg, HG-300; 600 mg/kg, HG-600, p.o.) and tetrahydroaminoacridine (10 mg/kg, p.o., THA-10) 6 times per week for 5 weeks. The number of arm entries (A) and spontaneous alternation score (B) were recorded. Data are expressed as the mean±SD (n=8). Means with different superscripts are significantly different (P<0.05).
